These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29773909)
1. An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Mayer FP; Schmid D; Owens WA; Gould GG; Apuschkin M; Kudlacek O; Salzer I; Boehm S; Chiba P; Williams PH; Wu HH; Gether U; Koek W; Daws LC; Sitte HH Neuropsychopharmacology; 2018 Nov; 43(12):2408-2417. PubMed ID: 29773909 [TBL] [Abstract][Full Text] [Related]
2. Role of Organic Cation Transporter 3 and Plasma Membrane Monoamine Transporter in the Rewarding Properties and Locomotor Sensitizing Effects of Amphetamine in Male andFemale Mice. Clauss NJ; Koek W; Daws LC Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948221 [TBL] [Abstract][Full Text] [Related]
3. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux. Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432 [TBL] [Abstract][Full Text] [Related]
13. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634 [TBL] [Abstract][Full Text] [Related]
14. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants. Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035 [TBL] [Abstract][Full Text] [Related]
15. Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine. Covey DP; Juliano SA; Garris PA PLoS One; 2013; 8(5):e60763. PubMed ID: 23671560 [TBL] [Abstract][Full Text] [Related]
16. Orchestration of Dopamine Neuron Population Activity in the Ventral Tegmental Area by Caffeine: Comparison With Amphetamine. Valenti O; Zambon A; Boehm S Int J Neuropsychopharmacol; 2021 Oct; 24(10):832-841. PubMed ID: 34278424 [TBL] [Abstract][Full Text] [Related]
17. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems. Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward. Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351 [TBL] [Abstract][Full Text] [Related]
19. Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation. Vicente-Rodríguez M; Rojo Gonzalez L; Gramage E; Fernández-Calle R; Chen Y; Pérez-García C; Ferrer-Alcón M; Uribarri M; Bailey A; Herradón G Eur Neuropsychopharmacol; 2016 Nov; 26(11):1794-1805. PubMed ID: 27642078 [TBL] [Abstract][Full Text] [Related]
20. Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Underhill SM; Wheeler DS; Li M; Watts SD; Ingram SL; Amara SG Neuron; 2014 Jul; 83(2):404-416. PubMed ID: 25033183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]